{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T05:43:42Z","timestamp":1790833422256,"version":"4.1.0"},"reference-count":116,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2004,1,1]],"date-time":"2004-01-01T00:00:00Z","timestamp":1072915200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["neurotox res"],"published-print":{"date-parts":[[2004,1]]},"DOI":"10.1007\/bf03033223","type":"journal-article","created":{"date-parts":[[2009,7,20]],"date-time":"2009-07-20T17:18:13Z","timestamp":1248110293000},"page":"213-224","source":"Crossref","is-referenced-by-count":41,"title":["Role of endocannabinoid system in mental diseases"],"prefix":"10.1007","volume":"6","author":[{"given":"Jorge","family":"Manzanares","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leyre","family":"Urig\u00fcen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriel","family":"Rubio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tom\u00e1s","family":"Palomo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"BF03033223_CR1","volume-title":"Diagnostic and Statistical Manual of Mental Disorders, 4th Edition","author":"American Psychiatric Association","year":"1994","unstructured":"American Psychiatric Association (1994)Diagnostic and Statistical Manual of Mental Disorders, 4th Edition (DSM-IV) (APA: Washington, DC)."},{"key":"BF03033223_CR2","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/S1474-4422(03)00381-8","volume":"2","author":"D Baker","year":"2003","unstructured":"Baker D, G Pryce, G Giovannoni and AJ Thompson (2003) The therapeutic potential of cannabis.Lancet Neurol. 2, 291\u2013298.","journal-title":"Lancet Neurol."},{"key":"BF03033223_CR3","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1126\/science.277.5329.1094","volume":"277","author":"M Beltramo","year":"1997","unstructured":"Beltramo M, N Stella, A Calignano, SY Lin, A Makriyannis and D Piomelli (1997) Functional role of high-affinity anandamide transport, as revealed by selective inhibition.Science 277, 1094\u20131097.","journal-title":"Science"},{"key":"BF03033223_CR4","doi-asserted-by":"crossref","first-page":"3315","DOI":"10.1074\/jbc.272.6.3315","volume":"272","author":"T Bisogno","year":"1997","unstructured":"Bisogno T, S Maurelli, D Melck, L De Petrocellis and V Di Marzo (1997) Biosynthesis, uptake, and degradation of anandamide and palmitoylethanolamide in leukocytes.J. Biol. Chem. 272, 3315\u20133323.","journal-title":"J. Biol. Chem."},{"key":"BF03033223_CR5","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1006\/bbrc.1999.0254","volume":"256","author":"T Bisogno","year":"1999","unstructured":"Bisogno T, F Berrendero, G Ambrosino, M Cebeira, JA Ramos, JJ Fernandez Ruiz and V Di Marzo (1999) Brain regional distribution of endocannabinoids: implications for their biosynthesis and biological function.Biochem. Biophys. Res. Commun. 256, 377\u2013380.","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"BF03033223_CR6","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1042\/bj3120637","volume":"312","author":"M Bouaboula","year":"1995","unstructured":"Bouaboula M, C Poinot-Chazel, B Bourrie, X Canat, B Calandra, M Rinaldi-Carmona, G Le Fur and P Casellas (1995) Activation of mitogen-activated protein kinases by stimulation of the central cannabinoid receptor CB1.Biochem. J. 312, 637\u2013641.","journal-title":"Biochem. J."},{"key":"BF03033223_CR7","doi-asserted-by":"crossref","first-page":"2033","DOI":"10.1176\/appi.ajp.158.12.2033","volume":"158","author":"GB Bovasso","year":"2001","unstructured":"Bovasso GB (2001) Cannabis abuse as a risk factor for depressive symptoms.Am. J. Psychiatry 158, 2033\u20132037.","journal-title":"Am. J. Psychiatry"},{"key":"BF03033223_CR8","doi-asserted-by":"crossref","first-page":"1679","DOI":"10.1046\/j.1360-0443.2000.951116798.x","volume":"95","author":"C Coffey","year":"2000","unstructured":"Coffey C, M Lynskey, R Wolfe and GC Patton (2000) Initiation and progression of cannabis use in a population-based Australian adolescent longitudinal study.Addiction 95, 1679\u20131690.","journal-title":"Addiction"},{"key":"BF03033223_CR9","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/S0740-5472(00)00148-3","volume":"20","author":"J Copeland","year":"2001","unstructured":"Copeland J, W Swift and V Rees (2001a) Clinical profile of participants in a brief intervention program for cannabis use disorders.J. Subst. Abuse Treat. 20, 45\u201352.","journal-title":"J. Subst. Abuse Treat."},{"key":"BF03033223_CR10","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/S0740-5472(01)00179-9","volume":"21","author":"J Copeland","year":"2001","unstructured":"Copeland J, W Swift, R Roffman and R Stephens (2001b) A randomized controlled trial of brief cognitive-behavioral interventions for cannabis use disorder.J. Subst. Abuse Treat. 21, 55\u201364.","journal-title":"J. Subst. Abuse Treat."},{"key":"BF03033223_CR11","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1016\/S0024-3205(99)00016-8","volume":"64","author":"J Corchero","year":"1999","unstructured":"Corchero J, JA Fuentes and J Manzanares (1999) Chronic administration with the cannabinoid receptor agonist CP-55, 940 regulates corticotropin releasing factor and proopiomelanocortin gene expression in the hypothalamus and pituitary gland of the rat.Life Sci. 64, 905\u2013911.","journal-title":"Life Sci."},{"key":"BF03033223_CR12","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1038\/384083a0","volume":"384","author":"BF Cravatt","year":"1996","unstructured":"Cravatt BF, DK Giang, SP Mayfield, DL Boger, RA Lerner and NB Gilula (1996) Molecular characterization of an enzyme that degrades neuromodulatory fatty-acid amides.Nature 384, 83\u201387.","journal-title":"Nature"},{"key":"BF03033223_CR13","doi-asserted-by":"crossref","first-page":"9371","DOI":"10.1073\/pnas.161191698","volume":"98","author":"BF Cravatt","year":"2001","unstructured":"Cravatt BF, K Demarest, MP Patricelli, MH Bracey, DK Giang, BR Martin and AH Lichtman (2001) Supersensitivity to anandamide and enhanced endogenous cannabinoid signalling in mice lacking fatty acid amide hydrolase.Proc. Natl. Acad. Sci. USA 98, 9371\u20139376.","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"BF03033223_CR14","doi-asserted-by":"crossref","first-page":"179","DOI":"10.2165\/00023210-200317030-00004","volume":"17","author":"JL Croxford","year":"2003","unstructured":"Croxford JL (2003) Therapeutic potential of cannabi-noids in CNS disease.CNS Drugs 17, 179\u2013202.","journal-title":"CNS Drugs"},{"key":"BF03033223_CR15","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/S0306-4522(00)00552-2","volume":"103","author":"B Dean","year":"2001","unstructured":"Dean B, S Sundram, R Bradbury, E Scarr and D Copolov (2001) Studies on [3H]CP-55940 binding in the human central nervous system: regional specific changes in density of cannabinoid-1 receptors associated with schizophrenia and cannabis use.Neuroscience 103, 9\u201315.","journal-title":"Neuroscience"},{"key":"BF03033223_CR16","doi-asserted-by":"crossref","first-page":"1603","DOI":"10.1046\/j.1360-0443.2001.961116037.x","volume":"96","author":"L Degenhardt","year":"2001","unstructured":"Degenhardt L, W Hall and MT Lynskey (2001a) Alcohol, cannabis and tobacco use among Australians: a comparison of their associations with other drug use and use disorders, affective and anxiety disorders, and psychosis.Addiction 96, 1603\u20131614.","journal-title":"Addiction"},{"key":"BF03033223_CR17","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/S0376-8716(01)00130-2","volume":"64","author":"L Degenhardt","year":"2001","unstructured":"Degenhardt L, W Hall and M Lynskey (2001b) The relationships between cannabis use and other substance use in the general population.Drug Alcohol Depend. 64, 319\u2013327.","journal-title":"Drug Alcohol Depend."},{"key":"BF03033223_CR18","doi-asserted-by":"crossref","first-page":"6967","DOI":"10.1074\/jbc.M003161200","volume":"276","author":"DG Deutsch","year":"2001","unstructured":"Deutsch DG, ST Glaser, JM Howell, JS Kunz, RA Puffenbarger, CJ Hillard and N Abumrad (2001) The cellular uptake of anan-damide is coupled to its breakdown by fatty-acid amide hydro-lase.J. Biol. Chem. 276, 6967\u20136973.","journal-title":"J. Biol. Chem."},{"key":"BF03033223_CR19","doi-asserted-by":"crossref","first-page":"1946","DOI":"10.1126\/science.1470919","volume":"258","author":"WA Devane","year":"1992","unstructured":"Devane WA, L Hanus, A Breuer, RG Pertwee, LA Stevenson, G Griffin, D Gibson, A Mandelbaum, A Etiger and R Mechoulam (1992) Isolation and structure of a brain constituent that binds to the cannabinoid receptor.Science 258, 1946\u20131949.","journal-title":"Science"},{"key":"BF03033223_CR20","doi-asserted-by":"crossref","first-page":"5274","DOI":"10.1073\/pnas.85.14.5274","volume":"85","author":"G Chiara Di","year":"1988","unstructured":"Di Chiara G and A Imperato (1988) Drugs abused by humans preferentially increase synaptic dopamine concentrations in the mesolimbic system of freely moving rats.Proc. Natl. Acad. Sci. USA 85, 5274\u20135278.","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"BF03033223_CR21","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1038\/372686a0","volume":"372","author":"V Marzo Di","year":"1994","unstructured":"Di Marzo V, A Fontana, H Cadas, S Schinelli, G Cimino, JC Schwartz and D Piomelli (1994) Formation and inactivation of endogenous cannabinoid anandamide in central neurons.Nature 372, 686\u2013691.","journal-title":"Nature"},{"key":"BF03033223_CR22","doi-asserted-by":"crossref","first-page":"2081","DOI":"10.1098\/rspb.1998.0543","volume":"265","author":"M Egertova","year":"1998","unstructured":"Egertova M, DK Giang, BF Cravatt and MR Elphick (1998) A new perspective on cannabinoid signalling: complementary localization of fatty acid amide hydrolase and the CB1 receptor in rat brain.Proc. R Soc. Lond. Biol. Sci. 265, 2081\u20132085.","journal-title":"Proc. R Soc. Lond. Biol. Sci."},{"key":"BF03033223_CR23","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1098\/rstb.2000.0787","volume":"356","author":"MR Elphick","year":"2001","unstructured":"Elphick MR and M Egertova (2001) The neurobiology and evolution of cannabinoid signalling.Philos. Trans. R Soc. Lond. B Biol. Sci. 356, 381\u2013408.","journal-title":"Philos. Trans. R Soc. Lond. B Biol. Sci."},{"key":"BF03033223_CR24","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1146\/annurev.pharmtox.38.1.179","volume":"38","author":"CC Felder","year":"1998","unstructured":"Felder CC and M Glass (1998) Cannabinoid receptors and their endogenous agonists.Annu. Rev. Pharmacol. Toxicol. 38, 179\u2013200.","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"key":"BF03033223_CR25","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/0014-5793(96)00891-5","volume":"393","author":"CC Felder","year":"1996","unstructured":"Felder CC, A Nielsen, EM Briley, M Palkovits, J Priller, J Axelrod, DN Nguyen, JM Richardson, RM Riggin, GA Koppel, SM Paul and GW Becker (1996) Isolation and measurement of the endogenous cannabinoid receptor agonist, anandamide in brain and peripheral tissues of human and rat.FEBS Lett. 393, 231\u2013235.","journal-title":"FEBS Lett."},{"key":"BF03033223_CR26","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1046\/j.1360-0443.2000.9545053.x","volume":"95","author":"DM Fergusson","year":"2000","unstructured":"Fergusson DM and LJ Horwood (2000) Does cannabis use encourage other forms of illicit drug use? Addiction95, 505\u2013520.","journal-title":"Addiction"},{"key":"BF03033223_CR27","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1016\/S0024-3205(99)00290-8","volume":"65","author":"JA Fuentes","year":"1999","unstructured":"Fuentes JA, M Ruiz-Gayo, J Manzanares, G Vela, I Reche and J Corchero (1999) Cannabinoids as potential new analgesics.Life Sci. 65, 675\u2013685.","journal-title":"Life Sci."},{"key":"BF03033223_CR28","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1016\/0091-3057(91)90365-9","volume":"40","author":"EL Gardner","year":"1991","unstructured":"Gardner EL and JH Lowinson (1991) Marijuana\u2019s interaction with brain reward systems: update 1991.Pharmacol. Biochem. Behav. 40, 571\u2013580.","journal-title":"Pharmacol. Biochem. Behav."},{"key":"BF03033223_CR29","first-page":"199","volume-title":"Substance Abuse. A Comprehensive Texbook","author":"L Grispoon","year":"1997","unstructured":"Grispoon L and JB Bakalar (1997) Marihuana, In:Substance Abuse. A Comprehensive Texbook (3rd Edition) (Lovinson JH, P Ruiz, RB Millman and JG Langrod, Eds.) (Williams and Wilkins: Baltimore, MD), pp 199\u2013206.","edition":"(3rd Edition)"},{"key":"BF03033223_CR30","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/S0376-8716(00)00171-X","volume":"62","author":"W Hall","year":"2001","unstructured":"Hall W (2001) Reducing the harms caused by cannabis use: the policy debate in Australia.Drug Alcohol Depend. 62, 163\u2013174.","journal-title":"Drug Alcohol Depend."},{"key":"BF03033223_CR31","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1046\/j.1360-0443.2000.9544851.x","volume":"95","author":"W Hall","year":"2000","unstructured":"Hall W and TF Babor (2000) Cannabis use and public health: assessing the burden.Addiction 95, 485\u2013490.","journal-title":"Addiction"},{"key":"BF03033223_CR32","doi-asserted-by":"crossref","first-page":"1611","DOI":"10.1016\/S0140-6736(98)05021-1","volume":"352","author":"W Hall","year":"1998","unstructured":"Hall W and N Solowij (1998) Adverse effects of cannabis.Lancet 352, 1611\u20131616.","journal-title":"Lancet"},{"key":"BF03033223_CR33","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1111\/j.1467-842X.2000.tb00500.x","volume":"24","author":"W Hall","year":"2000","unstructured":"Hall W and W Swift (2000) The THC content of cannabis in Australia: evidence and implications.Austr. NZ J. Publ. Health 24, 503\u2013507.","journal-title":"Austr. NZ J. Publ. Health"},{"key":"BF03033223_CR34","first-page":"69","volume-title":"Health Effects of Cannabis","author":"W Hall","year":"1999","unstructured":"Hall W, L Johnston and N Donnelly (1999) Epidemiology of cannabis use and its consequences, In:Health Effects of Cannabis (Kalant H, WA Corrigall, W Hall and RG Smart, Eds.) (Centre for Addiction and Mental Health: Toronto, Canada), pp 69\u2013125."},{"key":"BF03033223_CR35","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1046\/j.1460-9568.2002.02192.x","volume":"16","author":"J Haller","year":"2002","unstructured":"Haller J, N Bakos, M Szirmay, C Ledent and TF Freund (2002) The effects of genetic and pharmacological blockade of the CB1 cannabinoid receptor on anxiety.Eur. J. Neurosci. 16, 1395\u20131398.","journal-title":"Eur. J. Neurosci."},{"key":"BF03033223_CR36","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1007\/s002130050848","volume":"141","author":"M Haney","year":"1999","unstructured":"Haney M, AS Ward, SD Comer, RW Foltin and MW Fischman (1999a) Abstinence symptoms following oral THC administration to humans.Psychopharmacology 141, 385\u2013394.","journal-title":"Psychopharmacology"},{"key":"BF03033223_CR37","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1007\/s002130050849","volume":"141","author":"M Haney","year":"1999","unstructured":"Haney M, AS Ward, SD Comer, RW Foltin and MW Fischman (1999b) Abstinence symptoms following smoked marijuana in humans.Psychopharmacology 141, 395\u2013404.","journal-title":"Psychopharmacology"},{"key":"BF03033223_CR38","doi-asserted-by":"crossref","first-page":"3662","DOI":"10.1073\/pnas.061029898","volume":"98","author":"L Hanus","year":"2001","unstructured":"Hanus L, S Abu-Lafi, E Fride, A Breuer, Z Vogel, DE Shalev, I Kustanovich and R Mechoulam (2001) 2-Arachidonyl glyceryl ether, an endogenous agonist of the cannabinoid CB1 receptor.Proc. Natl. Acad. Sci. USA 98, 3662\u20133665.","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"BF03033223_CR39","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1523\/JNEUROSCI.11-02-00563.1991","volume":"11","author":"M Herkenham","year":"1991","unstructured":"Herkenham M, AB Lynn, MR Johnson, LS Melvin, BR de Costa and KC Rice (1991) Characterization and localization of cannabinoid receptors in rat brain: a quantitativein vitro autora-diographic study.J. Neurosci. 11, 563\u2013583.","journal-title":"J. Neurosci."},{"key":"BF03033223_CR40","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/S0026-895X(25)13196-9","volume":"33","author":"AC Howlett","year":"1988","unstructured":"Howlett AC, MR Johnson, LS Melvin and GM Milne (1988) Non-classical cannabinoid analgetics inhibit adenylate cyclase: development of a cannabinoid receptor model.Mol. Pharmacol. 33, 297\u2013302.","journal-title":"Mol. Pharmacol."},{"key":"BF03033223_CR41","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1124\/pr.54.2.161","volume":"54","author":"AC Howlett","year":"2002","unstructured":"Howlett AC, F Barth, TI Bonner, G Cabral, P Casellas, WA Devane, CC Felder, M Herkenham, K Mackie, BR Martin, R Mechoulam and RG Pertwee (2002) International union of pharmacology. XXVII: Classification of cannabinoid receptors.Pharmacol. Rev. 54, 161\u2013202.","journal-title":"Pharmacol. Rev."},{"key":"BF03033223_CR42","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1038\/sj.mp.4001376","volume":"9","author":"BL Hungund","year":"2004","unstructured":"Hungund BL, KY Vinod, SA Kassir, BS Basavarajappa, R Yalamanchili, TB Cooper, JJ Mann and V Arango (2004) Upregulation of CB(1) receptors and agonist-stimulated [35S] GTP?S binding in the prefrontal cortex of depressed suicide victims.Mol. Psychiatry 9, 184\u2013190.","journal-title":"Mol. Psychiatry"},{"key":"BF03033223_CR43","doi-asserted-by":"crossref","first-page":"1567","DOI":"10.1038\/sj.bjp.0702228","volume":"125","author":"DM Hutcheson","year":"1998","unstructured":"Hutcheson DM, ET Tzavara, C Smadja, E Valjent, BP Roques, J Hanoune and R Maldonado (1998) Behavioural and biochemical evidence for signs of abstinence in mice chronically treated with ?9-tetrahydrocannabinol.B r. J. Pharmacol. 125, 1567\u20131577.","journal-title":"B r. J. Pharmacol."},{"key":"BF03033223_CR44","doi-asserted-by":"crossref","first-page":"2023","DOI":"10.1111\/j.1476-5381.1996.tb15639.x","volume":"118","author":"EJ Ishac","year":"1996","unstructured":"Ishac EJ, L Jiang, KD Lake, K Varga, ME Abood and G Kunos (1996) Inhibition of exocytotic noradrenaline release by presy-naptic cannabinoid CB1 receptors on peripheral sympathetic nerves.Br. J. Pharmacol. 118, 2023\u20132028.","journal-title":"Br. J. Pharmacol."},{"key":"BF03033223_CR45","volume-title":"The Science of Marijuana","author":"LL Iversen","year":"2000","unstructured":"Iversen LL (2000)The Science of Marijuana (Oxford University Press: Oxford, England)."},{"key":"BF03033223_CR46","doi-asserted-by":"crossref","first-page":"1252","DOI":"10.1093\/brain\/awg143","volume":"126","author":"LL Iversen","year":"2003","unstructured":"Iversen LL (2003) Cannabis and the brain. Brain126, 1252\u20131270","journal-title":"Brain"},{"key":"BF03033223_CR47","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/S1471-4892(01)00120-5","volume":"2","author":"LL Iversen","year":"2002","unstructured":"Iversen LL and V Chapman (2002) Cannabinoids: a real prospect for pain relief?Curr. Opin. Pharmacol. 2, 50\u201355.","journal-title":"Curr. Opin. Pharmacol."},{"key":"BF03033223_CR48","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1192\/bjp.178.2.116","volume":"178","author":"A Johns","year":"2001","unstructured":"Johns A (2001) Psychiatric effects of cannabis.B r. J. Psychiatry 178, 116\u2013122.","journal-title":"B r. J. Psychiatry"},{"key":"BF03033223_CR49","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1007\/PL00005377","volume":"359","author":"M Kathmann","year":"1999","unstructured":"Kathmann M, U Bauer, E Schlicker and M Gothert (1999) Cannabinoid CB1 receptor-mediated inhibition of NMDA- and kainate-stimulated noradrenaline and and dopamine release in the brain.Naunyn Schmiedebergs Arch. Pharmacol. 359, 466\u2013470.","journal-title":"Naunyn Schmiedebergs Arch. Pharmacol."},{"key":"BF03033223_CR50","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1016\/S0306-4522(00)00286-4","volume":"100","author":"I Katona","year":"2000","unstructured":"Katona I, B Sperlagh, Z Magloczky, E Santha, A Kofalvi, S Czirjak, K Mackie, ES Vizi and TF Freund (2000) GABAergic interneu-rons are the targets of cannabinoid actions in the human hippocampus.Neuroscience 100, 797\u2013804.","journal-title":"Neuroscience"},{"key":"BF03033223_CR51","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/0165-6147(92)90060-J","volume":"13","author":"GF Koob","year":"1992","unstructured":"Koob GF (1992) Drugs of abuse: anatomy, pharmacology and function of reward pathways.Trends Pharmacol. Sci. 13, 177\u2013184.","journal-title":"Trends Pharmacol. Sci."},{"key":"BF03033223_CR52","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1007\/s002130050951","volume":"143","author":"EM Kouri","year":"1999","unstructured":"Kouri EM, HG Pope and SE Lukas (1999) Changes in aggressive behavior during withdrawal from long-term marijuana use.Psychopharmacology 143, 302\u2013308.","journal-title":"Psychopharmacology"},{"key":"BF03033223_CR53","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/S0740-5472(99)00104-X","volume":"19","author":"E Lang","year":"2000","unstructured":"Lang E, M Engelander and T Brooke (2000) Report of an integrated brief intervention with self-defined problem cannabis users. J.Subst. Abuse Treat. 19, 111\u2013116.","journal-title":"Subst. Abuse Treat."},{"key":"BF03033223_CR54","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1080\/10298420290030514","volume":"4","author":"I Lastres-Becker","year":"2002","unstructured":"Lastres-Becker I, M Gomez, R de Miguel, JA Ramos and J Fernandez-Ruiz (2002) Loss of cannabinoid CB1 receptors in the basal ganglia in the late akinetic phase of rats with experimental Huntington\u2019s disease.Neurotoxicity Res. 4, 601\u2013608.","journal-title":"Neurotoxicity Res."},{"key":"BF03033223_CR55","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1126\/science.283.5400.401","volume":"283","author":"C Ledent","year":"1999","unstructured":"Ledent C, O Valverde, G Cossu, F Petitet, JF Aubert, F Beslot, GA Bohme, A Imperato, T Pedrazzini, BP Roques, G Vassart, W Fratta and M Parmentier (1999) Unresponsiveness to cannabi-noids and reduced addictive effects of opiates in CB1 receptor knockout mice.Science 283, 401\u2013404.","journal-title":"Science"},{"key":"BF03033223_CR56","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1002\/ajmg.10038","volume":"105","author":"S Leroy","year":"2001","unstructured":"Leroy S, N Griffon, MC Bourdel, JP Oli\u00e9, MF Poirier and MO Krebs (2001) Schizophrenia and the cannabinoid receptor type 1 (CB1): association study using a single-base polymorphism in coding exon 1.Am. J. Med. Gen. 105, 749\u2013752.","journal-title":"Am. J. Med. Gen."},{"key":"BF03033223_CR57","doi-asserted-by":"crossref","first-page":"1665","DOI":"10.1097\/00001756-199906030-00008","volume":"10","author":"FM Leweke","year":"1999","unstructured":"Leweke FM, A Giuffrida, U Wurster, HM Emrich and D Piomelli (1999) Elevated endogenous cannabinoids in schizophrenia.Neuroreport 10, 1665\u20131669.","journal-title":"Neuroreport"},{"key":"BF03033223_CR58","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1042\/bj3460835","volume":"346","author":"J Liu","year":"2000","unstructured":"Liu J, B Gao, F Mirshahi, AJ Sanyal, AD Khanolkar, A Makriyannis and G Kunos (2000) Functional CB1 cannabinoid receptors in human vascular endothelial cells.Biochem. J. 346, 835\u2013840.","journal-title":"Biochem. J."},{"key":"BF03033223_CR59","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1126\/science.290.5489.131","volume":"290","author":"K Low","year":"2000","unstructured":"Low K, F Crestani, R Keist, D Benke, I Brunig, JA Benson, JM Fritschy, T Rulicke, H Bluethmann, H Mohler and U Rudolph (2000) Molecular and neuronal substrate for the selective attenu ation of anxiety.Science 290, 131\u2013134.","journal-title":"Science"},{"key":"BF03033223_CR60","doi-asserted-by":"crossref","first-page":"13484","DOI":"10.1074\/jbc.275.18.13484","volume":"275","author":"M Maccarrone","year":"2000","unstructured":"Maccarrone M, M Bari, T Lorenzon, T Bisogno, V Di Marzo and A Finazzi-Agro (2000) Anandamide uptake by human endothelial cells and its regulation by nitric oxide.J. Biol. Chem. 275, 13484\u201313492.","journal-title":"J. Biol. Chem."},{"key":"BF03033223_CR61","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/S0165-6147(99)01339-5","volume":"20","author":"J Manzanares","year":"1999","unstructured":"Manzanares J, J Corchero, J Romero, JJ Fernandez-Ruiz, JA Ramos and JA Fuentes (1999a) Pharmacological and biochemical interactions between opioids and cannabinoids.Trends Pharmacol. Sci. 20, 287\u2013294.","journal-title":"Trends Pharmacol. Sci."},{"key":"BF03033223_CR62","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/S0006-8993(99)01756-4","volume":"21","author":"J Manzanares","year":"1999","unstructured":"Manzanares J, J Corchero and JA Fuentes (1999b) Opioid and cannabinoid receptor-mediated regulation of the increase in adrenocorticotropin hormone and corticosterone plasma concentrations induced by central administration of delta(9)-tetrahydro-cannabinol in rats.Brain Res. 21, 173\u2013179.","journal-title":"Brain Res."},{"key":"BF03033223_CR63","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1038\/nature00839","volume":"418","author":"G Marsicano","year":"2002","unstructured":"Marsicano G, CT Wotjak, SC Azad, T Bisogno, G Rammes, MG Cascio, H Hermann, J Tang, C Hofmann, W Zieglgansberger, V Di Marzo and B Lutz (2002) The endogenous cannabinoid system controls extinction of aversive memories.Nature 418, 530\u2013534.","journal-title":"Nature"},{"key":"BF03033223_CR64","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/S0306-4522(98)00052-9","volume":"85","author":"MC Martellotta","year":"1998","unstructured":"Martellotta MC, G Cossu, L Fattore, GL Gessa and W Fratta (1998) Self-administration of the cannabinoid receptor agonist WIN 55, 212-2 in drug-naive mice.Neuroscience 85, 327\u2013330.","journal-title":"Neuroscience"},{"key":"BF03033223_CR65","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1007\/s00213-001-0946-5","volume":"159","author":"M Martin","year":"2002","unstructured":"Martin M, C Ledent, M Parmentier, R Maldonado and O Valverde (2002) Involvement of CB1 cannabinoid receptors in emotional behaviour.Psychopharmacology 159, 379\u2013387.","journal-title":"Psychopharmacology"},{"key":"BF03033223_CR66","first-page":"5","volume":"2","author":"DC Mash","year":"1997","unstructured":"Mash DC (1997) D3 receptor binding in human brain during cocaine overdose.Mol. Psychiatry 2, 5\u20136.","journal-title":"Mol. Psychiatry"},{"key":"BF03033223_CR67","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1159\/000049309","volume":"34","author":"R Mass","year":"2001","unstructured":"Mass R, C Bardong, K Kindl and B Dahme (2001) Relationship between cannabis use, schizotypal traits, and cognitive function in healthy subjects.Psychopathology 34, 209\u2013214.","journal-title":"Psychopathology"},{"key":"BF03033223_CR68","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1038\/346561a0","volume":"346","author":"LA Matsuda","year":"1990","unstructured":"Matsuda LA, SJ Lolait, MJ Brownstein, AC Young and TI Bonner (1990) Structure of a cannabinoid receptor and functional expression of the cloned cDNA.Nature 346, 561\u2013564.","journal-title":"Nature"},{"key":"BF03033223_CR69","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/0091-3057(94)90475-8","volume":"49","author":"RD Mattes","year":"1994","unstructured":"Mattes RD, K Engelman, LM Shaw and MA Elsohly (1994) Cannabinoids and appetite stimulation.Pharmacol. Biochem. Behav. 49, 187\u2013195.","journal-title":"Pharmacol. Biochem. Behav."},{"key":"BF03033223_CR70","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1046\/j.1360-0443.2000.9544912.x","volume":"95","author":"R McGee","year":"2000","unstructured":"McGee R, S Williams, R Poulton and T Moffitt (2000) A longitudinal study of cannabis use and mental health from adolescence to early adulthood.Addiction 95, 491\u2013503.","journal-title":"Addiction"},{"key":"BF03033223_CR71","first-page":"103","volume-title":"The Principles and Practice of Addictions in Psychiatry","author":"C McKenna","year":"1997","unstructured":"McKenna C (1997) Substance-induced psychiatric disorders, InThe Principles and Practice of Addictions in Psychiatry (Miller NS, Ed.) (Saunder Company: Philadelphia), pp 103\u2013112."},{"key":"BF03033223_CR72","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1126\/science.168.3936.1159","volume":"168","author":"R Mechoulam","year":"1970","unstructured":"Mechoulam R (1970) Marihuana chemistry.Science 168, 1159\u20131166.","journal-title":"Science"},{"key":"BF03033223_CR73","first-page":"1","volume-title":"Cannabinoids as Therapeutic Agents","author":"R Mechoulam","year":"1986","unstructured":"Mechoulam R (1986) The pharmacohistory ofCannabis sativa, In:Cannabinoids as Therapeutic Agents (Mechoulam R, Ed.) (CRC Press: Boca Raton, FL) pp 1\u201319."},{"key":"BF03033223_CR74","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/0006-2952(95)00109-D","volume":"50","author":"R Mechoulam","year":"1995","unstructured":"Mechoulam R, S Ben-Shabat, L Hanus, M Ligumsky, NE Kaminski, AR Schatz, A Gopher, S Almog, BR Martin, DR Comptonet al. (1995) Identification of an endogenous 2-mono-glyceride, present in canine gut, that binds to cannabinoid receptors.Biochem. Pharmacol. 50, 83\u201390.","journal-title":"Biochem. Pharmacol."},{"key":"BF03033223_CR75","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1038\/365061a0","volume":"365","author":"S Munro","year":"1993","unstructured":"Munro S, KL Thomas and M Abu-Sharr (1993) Molecular characterization of a peripheral receptor for cannabinoids.Nature 365, 61\u201365.","journal-title":"Nature"},{"key":"BF03033223_CR76","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1007\/s002109900147","volume":"361","author":"M Nakazi","year":"2000","unstructured":"Nakazi M, U Bauer, T Nickel, M Kathmann and E Schlicker (2000) Inhibition of serotonin release in the mouse brain via presynaptic cannabinoid CB1 receptors.Naunyn Schmiedebergs Arch. Pharmacol. 361, 19\u201324.","journal-title":"Naunyn Schmiedebergs Arch. Pharmacol."},{"key":"BF03033223_CR77","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1097\/00001756-199701200-00023","volume":"8","author":"M Navarro","year":"1997","unstructured":"Navarro M, E Hernandez, RM Munoz, I del Arco, MA Villanua, MR Carrera and F Rodr\u00edguez de Fonseca (1997) Acute administration of the CB1 cannabinoid receptor antagonist SR 141716A induces anxiety-like responses in the rat.Neuroreport 8, 491\u2013496.","journal-title":"Neuroreport"},{"key":"BF03033223_CR78","doi-asserted-by":"crossref","first-page":"5344","DOI":"10.1523\/JNEUROSCI.21-14-05344.2001","volume":"21","author":"M Navarro","year":"2001","unstructured":"Navarro M, MRA Carrera, W Fratta, O Valverde, G Cossu, L Fattore, JA Chowen, R G\u00f3mez, I del Arco, MA Villanua, R Maldonado, GF Koob and F Rodr\u00edguez de Fonseca (2001) Functional interaction between opioid and cannabinoid receptors in drug self-administration.J. Neurosci. 21, 5344\u20135350.","journal-title":"J. Neurosci."},{"key":"BF03033223_CR79","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1007\/978-1-59259-710-9_66","volume-title":"Marihuana and Medicine","author":"JC Negrete","year":"1999","unstructured":"Negrete JC and K Gill (1999) Cannabis and schizophrenia: an overview of the evidence to date, In:Marihuana and Medicine (Nahas GG, KM Sutin, D Harvey and S Agurell, Eds.) (Humana Press: Totowa, NJ), pp 671\u2013682."},{"key":"BF03033223_CR80","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1046\/j.1471-4159.2003.01627.x","volume":"85","author":"JM Oliva","year":"2003","unstructured":"Oliva JM, S Ortiz, T Palomo and J Manzanares (2003) Behavioural and gene transcription alterations induced by spontaneous cannabinoid withdrawal in mice.J. Neurochem. 85, 94\u2013104.","journal-title":"J. Neurochem."},{"key":"BF03033223_CR81","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/0006-8993(93)90220-H","volume":"616","author":"A Oviedo","year":"1993","unstructured":"Oviedo A, J Glowa and M Herkenham (1993) Chronic cannabinoid administration alters cannabinoid receptor binding in rat brain: a quantitative autoradiographic study.Brain Res. 616, 293\u2013302.","journal-title":"Brain Res."},{"key":"BF03033223_CR82","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1136\/bmj.325.7374.1195","volume":"325","author":"GC Patton","year":"2002","unstructured":"Patton GC, C Coffey, JB Carlin, L Degenhardt, M Lynskey and W Hall (2002) Cannabis use and mental health in young people: cohort study.BMJ 325, 1195\u20131198.","journal-title":"BMJ"},{"key":"BF03033223_CR83","doi-asserted-by":"crossref","first-page":"635","DOI":"10.2174\/0929867306666220401124036","volume":"6","author":"RG Pertwee","year":"1999","unstructured":"Pertwee RG (1999) Pharmacology of cannabinoid receptor ligands.Curr. Med. Chem. 6, 635\u2013664.","journal-title":"Curr. Med. Chem."},{"key":"BF03033223_CR84","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1016\/S0301-0082(00)00031-9","volume":"63","author":"RG Pertwee","year":"2001","unstructured":"Pertwee RG (2001) Cannabinoid receptors and pain.Prog. Neurobiol. 63, 569\u2013611.","journal-title":"Prog. Neurobiol."},{"key":"BF03033223_CR85","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/S0165-6147(97)01115-2","volume":"19","author":"PV Piazza","year":"1998","unstructured":"Piazza PV and M Le Moal (1998) The role of stress in drug self-administration.Trends Pharmacol. Sci. 19, 67\u201374.","journal-title":"Trends Pharmacol. Sci."},{"key":"BF03033223_CR86","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1038\/sj.mp.4001278","volume":"8","author":"G Ponce","year":"2003","unstructured":"Ponce G, J Hoenicka, G Rubio, I Ampuero, MA Jimenez-Arriero, R Rodriguez-Jimenez, T Palomo and JA Ramos (2003) Association between cannabinoid receptor gene (CNR1) and childhood attention deficit\/hyperactivity disorder in Spanish male alcoholic patients.Mol. Psychiatry 8, 466\u2013467.","journal-title":"Mol. Psychiatry"},{"key":"BF03033223_CR87","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1192\/bjp.178.2.107","volume":"178","author":"P Robson","year":"2001","unstructured":"Robson P (2001) Therapeutic aspects of cannabis and cannabinoids.Br. J. Psychiatry 178, 107\u2013115.","journal-title":"Br. J. Psychiatry"},{"key":"BF03033223_CR88","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/0091-3057(94)90108-2","volume":"47","author":"F Rodriguez de Fonseca","year":"1994","unstructured":"Rodriguez de Fonseca F, MA Gorriti, JJ Fernandez-Ruiz, T Palomo and JA Ramos (1994) Down regulation of rat brain cannabinoid binding sites after chronic ?9-tetrahydrocannabinol treatment.Pharmacol. Biochem. Behav. 47, 33\u201340.","journal-title":"Pharmacol. Biochem. Behav."},{"key":"BF03033223_CR89","doi-asserted-by":"crossref","first-page":"2050","DOI":"10.1126\/science.276.5321.2050","volume":"276","author":"F Rodriguez de Fonseca","year":"1997","unstructured":"Rodriguez de Fonseca F, MR Carrera, M Navarro, GF Koob and F Weiss (1997) Activation of corticotrophin-releasing factor in the limbic system during cannabinoid withdrawal.Science 276, 2050\u20132054.","journal-title":"Science"},{"key":"BF03033223_CR90","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1007\/BF03033228","volume":"3","author":"F Rodriguez de Fonseca","year":"2001","unstructured":"Rodriguez de Fonseca F, MA Gorriti, A Bilbao, L Escuredo, LM Garcia-Segura, D Piomelli and M Navarro (2001) Role of the endogenous cannabinoid system as a modulator of dopamine transmission: implications for Parkinson\u2019s disease and schizophrenia.Neurotoxicity Res. 3, 23\u201335.","journal-title":"Neurotoxicity Res."},{"key":"BF03033223_CR91","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1139\/y78-154","volume":"56","author":"SH Roth","year":"1978","unstructured":"Roth SH (1978) Stereospecific presynaptic inhibitory effect of ?9-tetrahydrocannabinol on cholinergic transmission in the myen-teric plexus of the guinea pig.Can. J. Physiol. Pharmacol. 56, 968\u2013975.","journal-title":"Can. J. Physiol. Pharmacol."},{"key":"BF03033223_CR92","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/S0165-6147(00)01805-8","volume":"22","author":"E Schlicker","year":"2001","unstructured":"Schlicker E and M Kathmann (2001) Modulation of transmitter release via presynaptic cannabinoid receptors.Trends Pharmacol. Sci. 22, 565\u2013572.","journal-title":"Trends Pharmacol. Sci."},{"key":"BF03033223_CR93","doi-asserted-by":"crossref","first-page":"4322","DOI":"10.1523\/JNEUROSCI.16-14-04322.1996","volume":"16","author":"M Shen","year":"1996","unstructured":"Shen M, TM Piser, VS Seybold and SA Thayer (1996) Cannabinoid receptor agonists inhibit glutamatergic synaptic transmission in rat hippocampal cultures.J. Neurosci. 16, 4322\u20134334.","journal-title":"J. Neurosci."},{"key":"BF03033223_CR94","doi-asserted-by":"crossref","DOI":"10.1017\/CBO9780511526824","volume-title":"Cannabis and Cognitive Functioning","author":"N Solowij","year":"1998","unstructured":"Solowij N (1998)Cannabis and Cognitive Functioning (Cambridge University Press: Cambridge, UK)."},{"key":"BF03033223_CR95","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1001\/jama.287.9.1123","volume":"287","author":"N Solowij","year":"2002","unstructured":"Solowij N, RS Stephens, RA Roffman, TF Babor, R Kadden, M Miller, K Christiansen, B McRee and J Vendetti (2002) Cognitive functioning of long-term heavy cannabis users seeking treatment.JAMA 287, 1123\u20131131.","journal-title":"JAMA"},{"key":"BF03033223_CR96","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1136\/bmj.320.7227.108","volume":"320","author":"J Strang","year":"2000","unstructured":"Strang J, J Witton and W Hall (2000) Improving the quality of the cannabis debate: defining the different domains.BMJ 320, 108\u2013110.","journal-title":"BMJ"},{"key":"BF03033223_CR97","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/S0376-8716(99)00131-3","volume":"59","author":"W Swift","year":"2000","unstructured":"Swift W, W Hall and J Copeland (2000) One year follow-up of cannabis dependence among long-term users in Sydney, Australia.Drug Alcohol Depend. 59, 309\u2013318.","journal-title":"Drug Alcohol Depend."},{"key":"BF03033223_CR98","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1046\/j.1360-0443.2001.9657379.x","volume":"96","author":"W Swift","year":"2001","unstructured":"Swift W, W Hall and M Teesson (2001a) Cannabis use and dependence among Australian adults: results from the National Survey of Mental Health and Wellbeing.Addiction 96, 737\u2013748.","journal-title":"Addiction"},{"key":"BF03033223_CR99","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/S0376-8716(00)00197-6","volume":"63","author":"W Swift","year":"2001","unstructured":"Swift W, W Hall and M Teeson (2001b) Characteristics of DSM-IV and ICD-10 cannabis dependence among Australian adults: results from the National Survey of Mental Health and Wellbeing.Drug Alcohol Depend. 63, 147\u2013153.","journal-title":"Drug Alcohol Depend."},{"key":"BF03033223_CR100","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1046\/j.1471-4159.1999.0731084.x","volume":"73","author":"B Szabo","year":"1999","unstructured":"Szabo B, T Muller and H Koch (1999) Effects of cannabinoids on dopamine release in the corpus striatum and the nucleus accum-bensin vitro.J. Neurochem. 73, 1084\u20131089.","journal-title":"J. Neurochem."},{"key":"BF03033223_CR101","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1038\/80577","volume":"3","author":"G Tanda","year":"2000","unstructured":"Tanda G, P Munzar and SR Goldberg (2000) Self-administration behavior is maintained by the psychoactive ingredient of marijuana in squirrel monkeys.Nat. Neurosci. 3, 1073\u20131074.","journal-title":"Nat. Neurosci."},{"key":"BF03033223_CR102","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1192\/bjp.163.2.141","volume":"163","author":"H Thomas","year":"1993","unstructured":"Thomas H (1993) Psychiatric symptoms in cannabis users.Br. J. Psychiatry 163, 141\u2013149.","journal-title":"Br. J. Psychiatry"},{"key":"BF03033223_CR103","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/S0376-8716(96)01277-X","volume":"42","author":"H Thomas","year":"1996","unstructured":"Thomas H (1996) A community survey of adverse effects of cannabis use.Drug Alcohol Depend. 42, 201\u2013207.","journal-title":"Drug Alcohol Depend."},{"key":"BF03033223_CR104","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1097\/00041444-200010030-00008","volume":"10","author":"SJ Tsai","year":"2000","unstructured":"Tsai SJ, YC Wang and CJ Hong (2000) Association study of a cannabinoid receptor gene (CNR1) polymorphism and schizophrenia.Psychiatr. Genet. 10, 149\u2013151.","journal-title":"Psychiatr. Genet."},{"key":"BF03033223_CR105","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1038\/sj.mp.4001029","volume":"7","author":"H Ujike","year":"2002","unstructured":"Ujike H, M Takai, K Nakata, Y Tanaka, T Takeda, M Kodoma, Y Fujiwara, A Sakai and S Kuroda (2002) CNR1, central cannabi-noid receptor gene, associated with susceptibility to hebephrenic schizophrenia.Mol. Psychiatry 7, 515\u2013518.","journal-title":"Mol. Psychiatry"},{"key":"BF03033223_CR106","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1016\/j.neuropharm.2004.01.003","volume":"46","author":"L Urig\u00fcen","year":"2004","unstructured":"Urig\u00fcen L, S Perez-Rial, CL Ledent, T Palomo and J Manzanares (2004) Impaired action of anxiolytics in mice deficient in cannabinoid CB1 receptors.Neuropharmacology 46, 966\u2013973","journal-title":"Neuropharmacology"},{"key":"BF03033223_CR107","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1046\/j.1460-9568.2000.00929.x","volume":"12","author":"O Valverde","year":"2000","unstructured":"Valverde O, C Ledent, F Beslot, M Parmentier and BP Roques (2000) Reduction of stress-induced analgesia but not of exogenous opioid effects in mice lacking CB1 receptors.Eur. J. Neurosci. 12, 533\u2013539.","journal-title":"Eur. J. Neurosci."},{"key":"BF03033223_CR108","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1007\/BF03033139","volume":"5","author":"M Stelt van der","year":"2003","unstructured":"van der Stelt M, HH Hansen, WB Veldhuis, PR Bar, K Nicolay, GA Veldink, JFG Vliegenhart and HS Hansen (2003) Biosynthesis of endocannabinoids and their modes of action in neurodegenera-tive diseases.Neurotoxicity Res. 5, 183\u2013199.","journal-title":"Neurotoxicity Res."},{"key":"BF03033223_CR109","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/S0376-8716(01)00137-5","volume":"64","author":"K von Sydow","year":"2001","unstructured":"von Sydow K, R Lieb, H Pfister, M Hofler, H Sonntag and HU Wittchen (2001) The natural course of cannabis use, abuse and dependence over four years: a longitudinal community study of adolescents and young adults.Drug Alcohol Depend. 64, 347\u2013361.","journal-title":"Drug Alcohol Depend."},{"key":"BF03033223_CR110","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/S0925-4927(01)00104-4","volume":"107","author":"LN Voruganti","year":"2001","unstructured":"Voruganti LN, P Slomka, P Zabel, A Mattar and AG Awad (2001) Cannabis induced dopamine release: anin-vivo SPECT study.Psychiatry Res. Neuroimaging 107, 173\u2013177.","journal-title":"Psychiatry Res. Neuroimaging"},{"key":"BF03033223_CR111","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1016\/S0024-3205(99)00289-1","volume":"65","author":"JM Walker","year":"1999","unstructured":"Walker JM, AG Hohmann, WJ Martin, NM Strangman, SM Huang and K Tsou (1999) The neurobiology of cannabinoid analgesia.Life Sci. 65, 665\u2013673.","journal-title":"Life Sci."},{"key":"BF03033223_CR112","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1159\/000126646","volume":"59","author":"J Weidenfeld","year":"1994","unstructured":"Weidenfeld J, S Feldman and R Mechoulam (1994) Effect of the brain constituent anandamide, a cannabinoid receptor agonist, on the hypothalamo-pituitary-adrenal axis in the rat.Neuroendocrinology 59, 110\u2013112.","journal-title":"Neuroendocrinology"},{"key":"BF03033223_CR113","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/S0022-3565(25)10720-9","volume":"262","author":"SP Welch","year":"1992","unstructured":"Welch SP and DL Stevens (1992) Antinociceptive activity of intrathecally administered cannabinoids alone, and in combination with morphine, in mice.J. Pharm. Exp. Ther. 262, 10\u201318.","journal-title":"J. Pharm. Exp. Ther."},{"key":"BF03033223_CR114","doi-asserted-by":"crossref","first-page":"1967","DOI":"10.1126\/science.276.5321.1967","volume":"276","author":"I Wickelgren","year":"1997","unstructured":"Wickelgren I (1997) Marijuana: harder than thought.Science 276, 1967\u20131970.","journal-title":"Science"},{"key":"BF03033223_CR115","doi-asserted-by":"crossref","first-page":"1469","DOI":"10.1111\/j.1360-0443.1996.tb02251.x","volume":"91","author":"GA Wiesbeck","year":"1996","unstructured":"Wiesbeck GA, MA Schuckit, JA Kalmijn, JE Tipp, KK Bucholz and TL Smith (1996) An evaluation of the history of marijuana withdrawal syndrome in a large population.Addiction 91, 1469\u20131478.","journal-title":"Addiction"},{"key":"BF03033223_CR116","doi-asserted-by":"crossref","first-page":"5780","DOI":"10.1073\/pnas.96.10.5780","volume":"96","author":"A Zimmer","year":"1999","unstructured":"Zimmer A, AM Zimmer, AG Hohmann, M Herkenham and TI Bonner (1999) Increased mortality, hypoactivity, and hypoalge-sia in cannabinoid CB1 receptor knockout mice.Proc. Natl. Acad. Sci. USA 96, 5780\u20135785.","journal-title":"Proc. Natl. Acad. Sci. USA"}],"container-title":["Neurotoxicity Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF03033223.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF03033223\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF03033223","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,11]],"date-time":"2025-02-11T05:28:49Z","timestamp":1739251729000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF03033223"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,1]]},"references-count":116,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2004,1]]}},"alternative-id":["BF03033223"],"URL":"https:\/\/doi.org\/10.1007\/bf03033223","relation":{},"ISSN":["1029-8428","1476-3524"],"issn-type":[{"value":"1029-8428","type":"print"},{"value":"1476-3524","type":"electronic"}],"subject":[],"published":{"date-parts":[[2004,1]]}}}